Category: Wound and Tissue Management
Leg and Foot Ulcer Treatment Could Get Cheaper for Diabetics in the U.S.
(Vancouver, British Columbia) – Will diabetic foot ulcer and venous leg ulcer treatment be easier to get in the future? How will manufacturers adjust to the growing demands and unstable future o... Read More
New Wound Closure Technology Set To Triple In Value By 2025, Cannibalize Competitors
Register to receive a free Wound and Tissue Management Market Report Suite 2019 synopsis and brochure Traditionally, surgical wounds have been closed with sutures, staples, Steri-strips, Mastisol,... Read More
Stryker Acquires HyperBranch Medical Technology, Inc.
Register to receive a free US Market Report Suite for Wound and Tissue Management report synopsis and brochure Stryker announced the acquisition of privately-held HyperBranch Medical Technology, Inc... Read More
Cynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic Wounds
Register to receive a free Europe Market Report Suite for Wound and Tissue Management report synopsis and brochure Australian stem cell and regenerative medicine company Cynata Therapeutics L... Read More
Smith & Nephew Touts Results From Allevyn Life Adhesive Dressing Hip Fracture Trial
Register to receive a free Europe Market Report Suite for Wound and Tissue Management report synopsis and brochure Smith & Nephew released the results from a trial of its Allevyn Life multi-lay... Read More
Smith & Nephew Welcome Wound Biofilm Report Supporting Dressings
Biofilms are clusters of bacteria that, when present in chronic wounds, are linked to delayed healing, and are resistant to antimicrobial treatments.... Read More
Gecko Biomedical Receives CE Mark Approval for SETALUM Sealant
Gecko Biomedical (“Gecko”), a medical device company developing innovative polymers to support tissue reconstruction, announced today that it has received CE Mark approval for its SETALUM™ Seala... Read More
Cohera Medical, Inc. Announces Exclusive Distribution Agreement for Cohera’s Sylys Surgical Sealant in Japan
Under the terms of the distribution agreement, Terumo Corporation (a leading provider of high quality, innovative medical devices), will have the exclusive rights to market Sylys in Japan.... Read More- 2 of 2
- « Previous
- 1
- 2
